Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Neuromuscular Disorders : NMD
|
February 8, 2023
Chronic mimics of myasthenia gravis: a retrospective case series
Patrick Harrison, Joshua Barton, Antony Winkel
European Journal of Applied Physiology
|
June 11, 2025
Toward isolating perceptual and physiological contributors to heat sensitivity in multiple sclerosis: insights from a new experimental model
Timothy English, Joshua Barton, Nicole Vargas, et al.
Immunity, Inflammation and Disease
|
February 23, 2026
LSTM-Based Recurrent Neural Network Predicts Influenza-Like-Illness in Variable Climate Zones
Alfred Amendolara, Christopher Gowans, Joshua Barton, et al.
Neurology
|
February 10, 2017
Tumefactive demyelination following treatment for relapsing multiple sclerosis with alemtuzumab
Joshua Barton, Todd A Hardy, Sean Riminton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 11, 2021
Expansion of chronic MS lesions is associated with an increase of radial diffusivity in periplaque white matter
Samuel Klistorner, Michael H Barnett, Con Yiannikas, et al.
Plos One
|
April 26, 2018
Diffusivity in the core of chronic multiple sclerosis lesions
Alexander Klistorner, Chenyu Wang, Con Yiannikas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 20, 2020
Expansion of chronic lesions is linked to disease progression in relapsing-remitting multiple sclerosis patients
Samuel Klistorner, Michael H Barnett, Con Yiannikas, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 28, 2019
Lesion activity and chronic demyelination are the major determinants of brain atrophy in MS
Chenyu Wang, Michael H Barnett, Con Yiannikas, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society
|
November 25, 2020
Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies
Alexander Klistorner, James D Triplett, Michael H Barnett, et al.
Annals of Clinical and Translational Neurology
|
December 20, 2018
Pathophysiological basis of low contrast visual acuity loss in multiple sclerosis
James D Triplett, Con Yiannikas, Michael H Barnett, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Neuromuscular Disorders : NMD
|
February 8, 2023
Chronic mimics of myasthenia gravis: a retrospective case series
Patrick Harrison, Joshua Barton, Antony Winkel
European Journal of Applied Physiology
|
June 11, 2025
Toward isolating perceptual and physiological contributors to heat sensitivity in multiple sclerosis: insights from a new experimental model
Timothy English, Joshua Barton, Nicole Vargas, et al.
Immunity, Inflammation and Disease
|
February 23, 2026
LSTM-Based Recurrent Neural Network Predicts Influenza-Like-Illness in Variable Climate Zones
Alfred Amendolara, Christopher Gowans, Joshua Barton, et al.
Neurology
|
February 10, 2017
Tumefactive demyelination following treatment for relapsing multiple sclerosis with alemtuzumab
Joshua Barton, Todd A Hardy, Sean Riminton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 11, 2021
Expansion of chronic MS lesions is associated with an increase of radial diffusivity in periplaque white matter
Samuel Klistorner, Michael H Barnett, Con Yiannikas, et al.
Plos One
|
April 26, 2018
Diffusivity in the core of chronic multiple sclerosis lesions
Alexander Klistorner, Chenyu Wang, Con Yiannikas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 20, 2020
Expansion of chronic lesions is linked to disease progression in relapsing-remitting multiple sclerosis patients
Samuel Klistorner, Michael H Barnett, Con Yiannikas, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 28, 2019
Lesion activity and chronic demyelination are the major determinants of brain atrophy in MS
Chenyu Wang, Michael H Barnett, Con Yiannikas, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society
|
November 25, 2020
Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies
Alexander Klistorner, James D Triplett, Michael H Barnett, et al.
Annals of Clinical and Translational Neurology
|
December 20, 2018
Pathophysiological basis of low contrast visual acuity loss in multiple sclerosis
James D Triplett, Con Yiannikas, Michael H Barnett, et al.
Page
of 3